The UK’s life sciences property sector had a barnstorming 2021, with investment volumes reaching £2.5 billion. But a closer look at these figures shows that a sizeable proportion of the up-and-built stock has now been traded, leaving development or repurposing the prime focus for further stock opportunities.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Contacts
- Angus Minford
Partner, Newmark